Emerging miniaturized proteomic technologies to study cell signaling in clinical samples

Science Signaling

Volumn 2, Issue 93, 2009, Pages

  Gujral, Taranjit S ^a   MacBeath, Gavin ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CASPASE 3; IMATINIB; STAT3 PROTEIN; STAT5 PROTEIN;

CANCER CELL CULTURE; CELL COMMUNICATION; CELL LYSATE; CHRONIC MYELOID LEUKEMIA; CLINICAL ASSESSMENT; DIAGNOSTIC PROCEDURE; HUMAN; IMMUNOASSAY; NANOFLUIDICS; PATIENT CARE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; QUANTITATIVE ANALYSIS; SHORT SURVEY;

HUMANS; IMMUNOASSAY; LUMINESCENT MEASUREMENTS; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 77953681424     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.293pe64     Document Type: Short Survey

References (15)

1. R. A. O'Neill, A. Bhamidipati, X. Bi, D. Deb-Basu, L. Cahill, J. Ferrante, E. Gentalen, M. Glazer, J. Gossett, K. Hacker, Isoelectric focusing technology quantifies protein signaling in 25 cells. Proc. Natl. Acad. Sci. U.S.A. 103, 16153-16158 (2006). (Pubitemid 44717502)
2. A. C. Fan, D. Deb-Basu, M.W. Orban, J. R. Gotlib, Y. Natkunam, R. O'Neill, R. A. Padua, L. Xu, D. Taketa, A. E. Shirer, S. Beer, A. X. Yee, D. W. Voehringer, D. W. Felsher, Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens. Nat. Med. 15, 566-571 (2009).
3. C. M. Shachaf, O. D. Perez, S.Youssef, A. C. Fan, S. Elchuri, M. J. Goldstein, A. E. Shirer, O. Sharpe, J. Chen, D. J. Mitchell, M. Chang, G. P. Nolan, L. Steinman, D. W. Felsher, Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis. Blood 110, 2674-2684 (2007). (Pubitemid 47523192)
4. C. P. Paweletz, L. Charboneau, V. E. Bichsel, N. L. Simone, T. Chen, J. W. Gillespie, M. R. Emmert- Buck, M. J. Roth, I. E. Petricoin, L. A. Liotta, Reverse phase protein microarrays which capture disease progression show activation of prosurvival pathways at the cancer invasion front. Oncogene 20, 1981-1989 (2001). (Pubitemid 32458030)
5. U. T. Shankavaram, W. C. Reinhold, S. Nishizuka, S. Major, D. Morita, K. K. Chary, M. A. Reimers, U. Scherf, A. Kahn, D. Dolginow, J. Cossman, E. P. Kaldjian, D. A. Scudiero, E. Petricoin, L. Liotta, J. K. Lee, J. N.Weinstein, Transcript and protein expression profiles of the NCI-60 cancer cell panel: An integromic microarray study. Mol. Cancer Ther. 6, 820-832 (2007). (Pubitemid 46554552)
6. R. Jiang, C. Mircean, I. Shmulevich, D. Cogdell, Y. Jia, I. Tabus, K. Aldape, R. Sawaya, J. M. Bruner, G. N. Fuller, W. Zhang, Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays. Proteomics 6, 2964-2971 (2006). (Pubitemid 43806395)
7. S. Nishizuka, L. Charboneau, L. Young, S. Major, W. C. Reinhold, M. Waltham, H. Kouros-Mehr, K. J. Bussey, J. K. Lee, V. Espina, P. J. Munson, E. Petricoin III, L. A. Liotta, J. N.Weinstein, Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc. Natl. Acad. Sci. U.S.A. 100, 14229-14234 (2003). (Pubitemid 37499219)
8. Y. Lin, R. Huang, X. Cao, S. M. Wang, Q. Shi, R. P. Huang, Detection of multiple cytokines by protein arrays from cell lysate and tissue lysate. Clin. Chem. Lab. Med. 41, 139-145 (2003). (Pubitemid 36336702)
9. M. Sevecka, G. MacBeath, State-based discovery: A multidimensional screen for smallmolecule modulators of EGF signaling. Nat. Methods 3, 825-831 (2006). (Pubitemid 44445830)
10. Z. S. Boyd, Q. J. Wu, C. O'Brien, J. Spoerke, H. Savage, P. J. Fielder, L. Amler, Y.Yan, M. R. Lackner, Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reverse-phase protein microarrays. Mol. Cancer Ther. 7, 3695-3706 (2008).
11. S. M. Chan, J. Ermann, L. Su, C. G. Fathman, P. J. Utz, Protein microarrays for multiplex analysis of signal transduction pathways. Nat. Med. 10, 1390-1396 (2004). (Pubitemid 40022723)
12. D. Droll, J. Dong, Y. Chen, M. Grigsby, J. Mistry, S. Ji, F.51. development of a quantitative multiplex human soluble cytokine receptor assay panel using Luminex® xMAP® technology. Clin. Immunol. 127, S59-S60 (2008).
13. M. Kornacker, A. Roth, O. Christensen, J. Kratzschmar, G. Wensing, Quantification of vascular endothelial growth factor, interleukin-8, and basic fibroblast growth factor in plasma of cancer patients and healthy volunteers-comparison of ELISA and microsphere-based multiplexed immunoassay. Clin. Chem. Lab. Med. 46, 1256-1264 (2008).
14. S. C. Datta, M. R. Opp, Lipopolysaccharide-induced increases in cytokines in discrete mouse brain regions are detectable using Luminex xMAP® technology. J. Neurosci. Methods 175, 119-124 (2008).
15. This work was supported by awards from the W. M. Keck Foundation, and the Camille and Henry Dreyfus Foundation and by grants from the NIH (1 R01 GM072872, 1 R33 CA128726, and 1 R21 CA126720). T.S.G. is a Human Frontier Science Program Fellow